Project Grant 2036385
Award Date
7/1/21
Completion Date
12/31/21
Dollars Obligated
$256K
Federal Agency
Division of Industrial Innovation
Awardee
Avior Inc. (TXPKU9NECMH3)
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Durham, NC 27701, USA
Similar Awards
This $255,966 National Science Foundation Technology, Innovation, and Partnerships award to Nano-Product Engineering, LLC will support the development of an antiviral/antimicrobial micropowder for application to personal protective equipment and respiratory equipment surfaces. The award period is from September 15, 2022 through May 31, 2023. The project aims to improve the protective properties of commonly used PPE and respiratory equipment, which typically only provides passive protection and...
This $249,999 National Science Foundation project grant supports the development of a bioengineered nanobarrier spray to protect against SARS-CoV-2 and other viral infections of the nasopharynx. Funded under the NSF Engineering program (CFDA 47.041), the two-year award to the University of Southern California will support computational modeling of nanobarrier delivery via nasal applicator as well as efficacy testing in a coronavirus mouse model. Specifically, the university researchers will...
This $247,457 National Science Foundation project grant funded research on coupling COVID-19 respiratory droplet adsorption and photocatalysis through metal organic frameworks. The grant was awarded to Framergy Inc. on June 15, 2021 under the Engineering (47.041) federal grant program. The objective was to develop materials and techniques to capture and deactivate SARS-CoV-2 virus particles through the end date of November 30, 2021. The Engineering program seeks to improve quality of life and...
This $256,000 National Science Foundation Project Grant under the Engineering (47.041) program will support the development of a permanent ceramic antimicrobial coating technology by Nanoionix, LLC. The goal is to synthesize and deposit a pure ceramic coating on relevant substrates that exceeds EPA requirements for generating reactive oxygen species to inactivate viruses and bacteria. Nanoionix will conduct spectroscopic assessments to rapidly evaluate the types and numbers of reactive oxygen...
The National Science Foundation (NSF) awarded a $878,296 Cooperative Agreement to Surfplasma Inc., a minority-owned small business based in Gainesville, FL, to develop a rapid, low-temperature plasma prototype for disinfecting personal protective equipment (PPE), medical devices, food products and other materials from pathogens like COVID-19. The project, funded under NSF's Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to deliver a market-ready sterilization solution...
The National Science Foundation awarded a $255,981 Small Business Innovation Research Phase I Project Grant to Frezent Biological Solutions Inc. of Valhalla, NY under the Engineering (CFDA 47.041) federal grant program. The grant funds the development of a novel peptide inhibitor of the coronavirus papain-like protease as a prophylactic and antiviral therapeutic for COVID-19, to be administered via inhalation. The Engineering program seeks to improve quality of life and economic strength...
The National Science Foundation Division of Industrial Innovation awarded Air Company Holdings, Inc. a $256,000 Project Grant under the Engineering (47.041) federal grant program. The grant supports research to develop improved catalysts for sanitizer ethanol production to address needs during the COVID-19 pandemic. The award period is from May 15, 2021 through October 31, 2021 and will fund research at Air Company's Brooklyn, New York facility to advance catalyst technologies for sanitizer...
Nanored LLC received a $246,731 National Science Foundation Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to support the development of a novel SARS-CoV-2 virus-like particle optimized to deliver shRNA therapeutics from March 1, 2021 through April 30, 2022. The grant aims to prevent and treat COVID-19 infection through a delivery method utilizing virus-like particles to transport self-amplifying short hairpin RNA molecules into cells. The funding will...
The National Science Foundation awarded a $255,961 Small Business Technology Transfer Phase I Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to Rush River Research Corp. The grant aims to develop a low-cost, automated receptacle for rapid point-of-care sterilization of personal protective equipment, such as filtering facepiece respirators, for frontline healthcare workers during the COVID-19 pandemic. Specifically, the company will construct and...
The National Science Foundation Division of Industrial Innovation awarded $255,700 to Creative Biotherapeutics LLC through its Engineering program (CFDA 47.041) on January 15, 2021 to fund the project "SBIR PHASE I: STRESS PATHWAY INHIBITION PREVENTS COVID-19 INFECTION (COVID-19)." This Project Grant will support Creative Biotherapeutics' research efforts through December 31, 2021 to develop inhibitors of stress response pathways to prevent COVID-19 infection. The NSF Engineering...